DrugPatentWatch Report Store
Showing 681–720 of 905 results
- Sale!
SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM PHOSPHATE, MONOBASIC Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM PHOSPHATE, TRIBASIC, ANHYDROUS Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM POLYSTYRENE SULFONATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM PROPIONATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM STARCH GLYCOLATE TYPE A CORN Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM STARCH GLYCOLATE TYPE A Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM STARCH GLYCOLATE TYPE A POTATO Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM STEARATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM STEARYL FUMARATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM SULFATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SODIUM SULFITE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SOHONOS (palovarotene) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
SOLOSEC (secnidazole) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
SOLUPREP S (chlorhexidine gluconate; isopropyl alcohol) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
SORBIC ACID Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SORBITAN Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SORBITAN MONOLAURATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SORBITAN MONOOLEATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SORBITAN MONOSTEARATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SORBITAN SESQUIOLEATE Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SORBITOL Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SOTYKTU (deucravacitinib) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
SOYBEAN OIL Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
SPINRAZA (nusinersen sodium) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
SPRAVATO (esketamine hydrochloride) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
STARCH, CORN Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
STARCH, POTATO Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
STARCH, PREGELATINIZED CORN Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
STEARIC ACID Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
STEARYL ALCOHOL Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
STEGLUJAN (ertugliflozin; sitagliptin phosphate) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
STENDRA (avanafil) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
STIOLTO RESPIMAT (olodaterol hydrochloride; tiotropium bromide) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
STIVARGA (regorafenib) Drug Profile, 2024
$399.00 Add to cartBuy Now - Sale!
STRAWBERRY Drug Excipient Business Development Opportunity Report, 2024
$399.00 Add to cartBuy Now - Sale!
STRIBILD (cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate) Drug Profile, 2024
$399.00 Add to cartBuy Now